-
1
-
-
77950344360
-
Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity
-
doi: 10.1007/s10620-009-1111-y
-
Shafran I, Burgunder P. Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity. Dig Dis Sci. 2010. doi: 10.1007/s10620-009-1111-y
-
(2010)
Dig Dis Sci.
-
-
Shafran, I.1
Burgunder, P.2
-
2
-
-
2442699228
-
Specificities of inflammatory bowel disease in childhood
-
DOI 10.1016/j.bpg.2004.01.002, PII S1521691804000101
-
AM Griffiths 2004 Specificities of inflammatory bowel disease in childhood Best Pract Res Clin Gastroenterol 18 509 523 10.1016/j.bpg.2004.01.002 15157824 (Pubitemid 38667463)
-
(2004)
Best Practice and Research: Clinical Gastroenterology
, vol.18
, Issue.3
, pp. 509-523
-
-
Griffiths, A.M.1
-
3
-
-
0000153298
-
Enteric microflora in IBD: Pathogens or commensals?
-
10.1002/ibd.3780030309
-
RB Sartor 1997 Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis 3 230 235 10.1002/ibd.3780030309
-
(1997)
Inflamm Bowel Dis
, vol.3
, pp. 230-235
-
-
Sartor, R.B.1
-
4
-
-
0031781603
-
Inflammatory bowel disease: Etiology and pathogenesis
-
DOI 10.1016/S0016-5085(98)70381-6
-
C Fiocchi 1998 Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 182 205 10.1016/S0016-5085(98)70381-6 1:STN:280: DyaK1czitlGjtg%3D%3D 9649475 (Pubitemid 28307304)
-
(1998)
Gastroenterology
, vol.115
, Issue.1
, pp. 182-205
-
-
Fiocchi, C.1
-
5
-
-
51049094931
-
Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn's Disease
-
10.1111/j.1523-5378.2008.00607.x 1:CAS:528:DC%2BD1cXpslKns7w%3D 18665930
-
SM Man L Zhang AS Day S Leach HM Mitchell 2008 Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn's Disease Helicobacter 13 234 238 10.1111/j.1523-5378.2008.00607.x 1:CAS:528:DC%2BD1cXpslKns7w%3D 18665930
-
(2008)
Helicobacter
, vol.13
, pp. 234-238
-
-
Man, S.M.1
Zhang, L.2
Day, A.S.3
Leach, S.4
Mitchell, H.M.5
-
6
-
-
60849125086
-
Non-jejuni Campylobacter species are associated with Crohn's disease in children
-
10.1128/JCM.01949-08
-
L Zhang SM Man AS Day, et al. 2009 Non-jejuni Campylobacter species are associated with Crohn's disease in children J Clin Micro 47 453 455 10.1128/JCM.01949-08
-
(2009)
J Clin Micro
, vol.47
, pp. 453-455
-
-
Zhang, L.1
Man, S.M.2
Day, A.S.3
-
7
-
-
39649100206
-
Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora
-
DOI 10.1002/ibd.20330
-
A Swidsinski V Loening-Baucke M Vaneechoutte Y Doerffel 2008 Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora Inflamm Bowel Dis 14 147 161 10.1002/ibd.20330 18050295 (Pubitemid 351288036)
-
(2008)
Inflammatory Bowel Diseases
, vol.14
, Issue.2
, pp. 147-161
-
-
Swidsinski, A.1
Loening-Baucke, V.2
Vaneechoutte, M.3
Doerffel, Y.4
-
8
-
-
0035082973
-
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
-
DOI 10.1128/IAI.69.4.2277-2285.2001
-
HC Rath M Schultz R Freitag, et al. 2001 Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice Infect Immun 69 2277 2285 10.1128/IAI.69.4.2277-2285.2001 1:CAS:528: DC%2BD3MXisVSlsrw%3D 11254584 (Pubitemid 32241818)
-
(2001)
Infection and Immunity
, vol.69
, Issue.4
, pp. 2277-2285
-
-
Rath, H.C.1
Schultz, M.2
Freitag, R.3
Dieleman, L.A.4
Li, F.5
Linde, H.-J.6
Scholmerich, J.7
Sartor, R.B.8
-
9
-
-
0034116557
-
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice
-
10.1016/S0016-5085(00)70362-3 1:CAS:528:DC%2BD3cXktlaiurk%3D 10833484
-
KL Madsen JS Doyle MM Tavernini, et al. 2000 Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice Gastroenterology 118 1094 1105 10.1016/S0016-5085(00)70362-3 1:CAS:528:DC%2BD3cXktlaiurk%3D 10833484
-
(2000)
Gastroenterology
, vol.118
, pp. 1094-1105
-
-
Madsen, K.L.1
Doyle, J.S.2
Tavernini, M.M.3
-
10
-
-
0032962075
-
Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
-
DOI 10.1016/S0016-5085(99)70013-2
-
KL Madsen JS Doyle LD Jewell MM Tavernini RN Fedorak 1999 Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice Gastroenterology 116 1107 1114 10.1016/S0016-5085(99)70013-2 1:STN:280:DyaK1M3jvVyrtg%3D%3D 10220502 (Pubitemid 29203020)
-
(1999)
Gastroenterology
, vol.116
, Issue.5
, pp. 1107-1114
-
-
Madsen, K.L.1
Doyle, J.S.2
Jewell, L.D.3
Tavernini, M.M.4
Fedorak, R.N.5
-
11
-
-
0031915148
-
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
-
DOI 10.1016/S0016-5085(98)70476-7
-
GR D'Haens K Geboes M Peeters, et al. 1998 Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 262 267 10.1016/S0016-5085(98)70476-7 9453485 (Pubitemid 28093532)
-
(1998)
Gastroenterology
, vol.114
, Issue.2
, pp. 262-267
-
-
D'Haens, G.R.1
Geboes, K.2
Peeters, M.3
Baert, F.4
Penninckx, F.5
Rutgeerts, P.6
-
12
-
-
49849086533
-
Sustained modulation of intestinal microflora by exclusive enteral nutrition used to treat children with Crohn's disease
-
10.1111/j.1365-2036.2008.03796.x 1:CAS:528:DC%2BD1cXhtF2hs7%2FL 19145728
-
ST Leach HM Mitchell WR Eng L Zhang AS Day 2008 Sustained modulation of intestinal microflora by exclusive enteral nutrition used to treat children with Crohn's disease Aliment Pharmacol Ther 28 724 733 10.1111/j.1365-2036.2008. 03796.x 1:CAS:528:DC%2BD1cXhtF2hs7%2FL 19145728
-
(2008)
Aliment Pharmacol Ther
, vol.28
, pp. 724-733
-
-
Leach, S.T.1
Mitchell, H.M.2
Eng, W.R.3
Zhang, L.4
Day, A.S.5
-
13
-
-
68049093112
-
Antibiotics and probiotics in inflammatory bowel disease: Why, when, and how
-
10.1097/MOG.0b013e32832b20bf 1:CAS:528:DC%2BD1MXnsVegsrc%3D 19444096
-
C Prantera ML Scribano 2009 Antibiotics and probiotics in inflammatory bowel disease: why, when, and how Curr Opin Gastroenterol 25 329 333 10.1097/MOG.0b013e32832b20bf 1:CAS:528:DC%2BD1MXnsVegsrc%3D 19444096
-
(2009)
Curr Opin Gastroenterol
, vol.25
, pp. 329-333
-
-
Prantera, C.1
Scribano, M.L.2
-
14
-
-
23744444350
-
An open-label evaluation of rifaximin in the treatment of active Crohn's disease
-
DOI 10.1185/030079905X53252, 2931
-
I Shafran LK Johnson 2005 An open-label evaluation of rifaximin in the treatment of active Crohn's disease Curr Med Res Opin 1 1165 1169 10.1185/030079905X53252 (Pubitemid 41140719)
-
(2005)
Current Medical Research and Opinion
, vol.21
, Issue.8
, pp. 1165-1169
-
-
Shafran, I.1
Johnson, L.K.2
-
15
-
-
33646884826
-
Antibiotic treatment of Crohn's disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
-
DOI 10.1111/j.1365-2036.2006.02879.x
-
C Prantera H Lochs M Campieri, et al. 2006 Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin Aliment Pharmacol Ther 23 1117 1125 10.1111/j.1365-2036.2006.02879.x 1:CAS:528:DC%2BD28Xlt1aktb8%3D 16611272 (Pubitemid 43779351)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.23
, Issue.8
, pp. 1117-1125
-
-
Prantera, C.1
Lochs, H.2
Campieri, M.3
Scribano, M.L.4
Sturniolo, G.C.5
Castiglione, F.6
Cottone, M.7
-
16
-
-
70349751968
-
Use and safety of rifaximin in children with inflammatory bowel disease
-
10.1097/MPG.0b013e3181a0d269 1:CAS:528:DC%2BD1MXhtFOhtr3M
-
P Muniyappa R Gulati F Mohr V Hupertz 2009 Use and safety of rifaximin in children with inflammatory bowel disease Pediatr Gastroenterol Nutr 49 400 404 10.1097/MPG.0b013e3181a0d269 1:CAS:528:DC%2BD1MXhtFOhtr3M
-
(2009)
Pediatr Gastroenterol Nutr
, vol.49
, pp. 400-404
-
-
Muniyappa, P.1
Gulati, R.2
Mohr, F.3
Hupertz, V.4
-
17
-
-
37849015933
-
"ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy
-
18184139
-
DB Doman HJ Goldberg MI Golding 2008 "Ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy Am J Gastroenterol 103 251 252 18184139
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 251-252
-
-
Doman, D.B.1
Goldberg, H.J.2
Golding, M.I.3
|